Doctolib, France’s dominant healthtech unicorn, has acquired UK-based Doctorlink, its main British competitor, in a move that formally plants its flag in the United Kingdom. The deal, whose financial terms remain undisclosed, gives Doctolib immediate access to a substantial user base and established National Health Service integrations, accelerating its pan-European expansion at a time of rapid consolidation in digital health.

Doctorlink, founded in 2015, had raised £12 million and built a platform combining online symptom assessment, appointment scheduling, and video consultations. With more than 5 million registered patients in the UK, it integrated directly with major NHS clinical systems including EMIS and TPP, and had forged partnerships with GP practices and private insurers. This infrastructure now becomes the foundation of Doctolib’s British operations, avoiding the need to build local relationships from scratch.

The acquisition extends Doctolib’s footprint beyond its strongholds in France, Germany, and Italy. Already serving over 60 million patients and 300,000 healthcare professionals across those markets, the company now directly confronts UK incumbents such as Babylon Health and Livi. It also underscores a strategic bet: that a unified platform for appointment management, telemedicine, and practice software can work across Europe’s regulatory and insurance mosaics.

For the NHS, Doctolib’s arrival signals fresh investment in digital patient pathways. The company says it will expand the UK team and adapt its full suite—notably its teleconsultation and practice management tools—to the specific needs of the public health system. As governments push for faster, more accessible primary care, Doctolib’s move positions it as a leading consolidator in a fragmented market, leveraging both technology and scale to reshape how millions of Europeans access healthcare.

L’article Doctolib rachète son concurrent britannique et s'implante au Royaume-Uni est apparu en premier sur Maddyness - Le média pour comprendre l'économie de demain.